Article
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.
Clinical and translational science - 1 Sept 2022
Bråten Line Skute, Ingelman-Sundberg Magnus, Jukic Marin M, Molden Espen, Kringen Marianne Kristiansen
Abstract excerpt
Sertraline is a commonly used SSRI antidepressant drug, metabolized by CYP2C19 and CYP2B6, that exhibits a substantial interindividual variation in clinical response, of which only a part can be attributed to known genetic variants. In the current study we have examined the role of a newly discovered ultrarapid CYP2C:TG haplotype and CYP2B6 variants in order to identify the possible missing heritability for such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
